Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Current Dermatology Reports
Published in: Current Dermatology Reports 1/2014

01-03-2014 | Epidemiology (A Armstrong, Section Editor)

Updates in Rosacea: Epidemiology, Risk Factors, and Management Strategies

Authors: Jean-Phillip Okhovat, April W. Armstrong

Published in: Current Dermatology Reports | Issue 1/2014

Login to get access

Abstract

Rosacea is a chronic, inflammatory skin disease that affects more than 15 million people in the United States. It is associated with significant psychosocial, physical, and economic burden. The pathogenesis of rosacea is poorly understood. Initial events include dysregulation in cutaneous neurovascular control and neuroimmune communication. Exacerbating factors may include UV light and infectious agents. Recent therapeutic advances have increased treatment options. Such therapies include avoidance of potential triggers, topical therapies, and systemic therapies. Treatment is targeted at reducing facial erythema and eliminating inciting agents that may contribute to the disease process. The tetracycline class of antibiotics has been most extensively studied for systemic therapy. Novel agents such as α-2 agonists have increased therapeutic options in rosacea.
Literature
1.
Bickers DR, Lim HW, Margolis D, et al. The burden of skin diseases: 2004 a joint project of the American Academy of Dermatology Association and the Society for Investigative Dermatology. J Am Acad Dermatol. 2006;55(3):490–500.PubMedCrossRef
2.
Wilkin J, Dahl M, Detmar M, et al. Standard classification of rosacea: report of the National Rosacea Society Expert Committee on the Classification and Staging of Rosacea. J Am Acad Dermatol. 2002;46(4):584–7.PubMedCrossRef
3.
Baldwin HE. Diagnosis and treatment of rosacea: state of the art. J Drugs Dermatol JDD. 2012;11(6):725–30.
4.
Romanowicz M, Stephenson JJ, Del Rosso JQ, Lenhart G. Healthcare utilization and costs of patients with rosacea in an insured population. J Drugs Dermatol JDD. 2008;7(1):41–9.
5.
Bamford JT, Gessert CE, Renier CM, et al. Childhood stye and adult rosacea. J Am Acad Dermatol. 2006;55(6):951–5.PubMedCrossRef
6.
Augustin M, Herberger K, Hintzen S, Heigel H, Franzke N, Schafer I. Prevalence of skin lesions and need for treatment in a cohort of 90 880 workers. Br J Dermatol. 2011;165(4):865–73.PubMedCrossRef
7.
Khaled A, Hammami H, Zeglaoui F, et al. Rosacea: 244 Tunisian cases. Tunis Med. 2010;88(8):597–601.PubMed
8.
Kyriakis KP, Palamaras I, Terzoudi S, Emmanuelides S, Michailides C, Pagana G. Epidemiologic aspects of rosacea. J Am Acad Dermatol. 2005;53(5):918–9.PubMedCrossRef
9.
Spoendlin J, Voegel JJ, Jick SS, Meier CR. A study on the epidemiology of rosacea in the U.K. Br J Dermatol. 2012;167(3):598–605.PubMedCrossRef
10.
11.
Bae YI, Yun SJ, Lee JB, Kim SJ, Won YH, Lee SC. Clinical evaluation of 168 Korean patients with rosacea: the sun exposure correlates with the erythematotelangiectatic subtype. Ann Dermatol. 2009;21(3):243–9.PubMedCentralPubMedCrossRef
12.••
Steinhoff M, Schauber J, Leyden JJ. New insights into rosacea pathophysiology: a review of recent findings. J Am Acad Dermatol. 2013;69(6 Suppl 1):S15–26. This manuscript highlights the recent findings with regards to the innate immune system’s role in the pathophysiology of rosacea.
13.•
Jarmuda S, O’Reilly N, Zaba R, Jakubowicz O, Szkaradkiewicz A, Kavanagh K. Potential role of Demodex mites and bacteria in the induction of rosacea. J Med Microbiol. 2012;61(Pt 11):1504–10. This manuscript reveals the association between infectious agents and rosacea.
14.
Abram K, Silm H, Maaroos HI, Oona M. Risk factors associated with rosacea. J Eur Acad Dermatol Venereol JEADV. 2010;24(5):565–71.CrossRef
15.
Crawford GH, Pelle MT, James WD. Rosacea: I. Etiology, pathogenesis, and subtype classification. J Am Acad Dermatol. 2004;51(3):327–41. quiz 342–324.PubMedCrossRef
16.
Higgins E, du Vivier A. Alcohol intake and other skin disorders. Clin Dermatol. 1999;17(4):437–41.PubMedCrossRef
17.
Greaves MW, Burova EP. Flushing: causes, investigation and clinical consequences. J Eur Acad Dermatol Venereol. 1997;8(2):91–100.CrossRef
18.
Chen DM, Crosby DL. Periorbital edema as an initial presentation of rosacea. J Am Acad Dermatol. 1997;37(2 Pt 2):346–8.PubMedCrossRef
19.
Akpek EK, Merchant A, Pinar V, Foster CS. Ocular rosacea: patient characteristics and follow-up. Ophthalmology. 1997;104(11):1863–7.PubMedCrossRef
20.
Gupta AK, Chaudhry MM. Rosacea and its management: an overview. J Eur Acad Dermatol Venereol JEADV. 2005;19(3):273–85.CrossRef
21.
Breneman D, Savin R, VandePol C, Vamvakias G, Levy S, Leyden J. Double-blind, randomized, vehicle-controlled clinical trial of once-daily benzoyl peroxide/clindamycin topical gel in the treatment of patients with moderate to severe rosacea. Int J Dermatol. 2004;43(5):381–7.PubMedCrossRef
22.
Dahl MV, Jarratt M, Kaplan D, Tuley MR, Baker MD. Once-daily topical metronidazole cream formulations in the treatment of the papules and pustules of rosacea. J Am Acad Dermatol. 2001;45(5):723–30.PubMedCrossRef
23.
Bjerke R, Fyrand O, Graupe K. Double-blind comparison of azelaic acid 20% cream and its vehicle in treatment of papulo-pustular rosacea. Acta Derm Venereol. 1999;79(6):456–9.PubMedCrossRef
24.
Sauder D, Miller R, Gratton D, Danby W, Griffiths C, Phillips S. The treatment of rosacea: the safety and efficacy of sodium sulfacetamide 10% and sulfur 5% lotion (Novacet) is demonstrated in a double-blind study. J Dermatol Treat. 1997;8(2):79–85.CrossRef
25.
Kocak M, Yagli S, Vahapoglu G, Eksioglu M. Permethrin 5% cream versus metronidazole 0.75% gel for the treatment of papulopustular rosacea. A randomized double-blind placebo-controlled study. Dermatology (Basel, Switzerland). 2002;205(3):265–70.CrossRef
26.••
Fowler J, Jarratt M, Moore A, et al. Once-daily topical brimonidine tartrate gel 0.5% is a novel treatment for moderate to severe facial erythema of rosacea: results of two multicentre, randomized and vehicle-controlled studies. Br J Dermatol. 2012;166(3):633–41. This manuscript discusses randomized controlled trials regarding new therapeutic regimens available for rosacea, namely α-2 agonists.
27.
Shanler SD, Ondo AL. Successful treatment of the erythema and flushing of rosacea using a topically applied selective α1-adrenergic receptor agonist, oxymetazoline. Arch Dermatol. 2007;143(11):1369–71.PubMedCrossRef
28.
Del Rosso JQ, Webster GF, Jackson M, et al. Two randomized phase III clinical trials evaluating anti-inflammatory dose doxycycline (40-mg doxycycline, USP capsules) administered once daily for treatment of rosacea. J Am Acad Dermatol. 2007;56(5):791–802.PubMedCrossRef
29.
Frucht-Pery J, Sagi E, Hemo I, Ever-Hadani P. Efficacy of doxycycline and tetracycline in ocular rosacea. Am J Ophthalmol. 1993;116(1):88–92.PubMed
30.
Gollnick H, Blume-Peytavi U, Szabo EL, et al. Systemic isotretinoin in the treatment of rosacea–doxycycline- and placebo-controlled, randomized clinical study. J Dtsch Dermatol Ges J Ger Soc Dermatol JDDG. 2010;8(7):505–15.
31.••
Tan J, Berg M. Rosacea: Current state of epidemiology. J Am Acad Dermatol. 2013;69(6 Suppl 1):S27–35. This manuscript reviews the major epidemiologic data of rosacea.
Metadata
Title
Updates in Rosacea: Epidemiology, Risk Factors, and Management Strategies
Authors
Jean-Phillip Okhovat
April W. Armstrong
Publication date
01-03-2014
Publisher
Springer US
Published in
Current Dermatology Reports / Issue 1/2014
Electronic ISSN: 2162-4933
DOI
https://doi.org/10.1007/s13671-014-0070-5

Other articles of this Issue 1/2014

Current Dermatology Reports 1/2014 Go to the issue

Epidemiology (A Armstrong, Section Editor)

Merkel Cell Carcinoma: Epidemiology, Target, and Therapy

Epidemiology (A Armstrong, Section Editor)

Advanced Basal Cell Carcinoma: Epidemiology and Therapeutic Innovations

Immunology (HC Lima, Section Editor)

Allergy to Hematophagous Arthropods Bites

Epidemiology (A Armstrong, Section Editor)

Epidemiology of Hidradenitis Suppurativa: Prevalence, Pathogenesis, and Factors Associated with the Development of HS

Epidemiology (A Armstrong, Section Editor)

Epidemiology and Management of Acne in Adult Women

Epidemiology (A Armstrong, Section Editor)

Genetic Epidemiology of Psoriasis